PhotoCure ASA (FRA:PHS) Degree of Operating Leverage : 15.90 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:PHS PhotoCure ASA FRA:PHS
81 GF Score
Price €4.88
GF Value €6.61
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is PhotoCure ASA Degree of Operating Leverage?

PhotoCure ASA FRA:PHS 81 Degree of Operating Leverage is 15.90 as of Jun. 2026. GuruFocus rates FRA:PHS with a GF Score™ of 81/100 and a GF Value™ of €6.61 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 933 Drug Manufacturers companies, PhotoCure ASA ranks worse than 86.39% on this metric.

Degree of Operating Leverage (DOL) measures the percentage change in EBIT for a unit change in Revenue. PhotoCure ASA's Degree of Operating Leverage for the quarter that ended in Jun. 2026 was 15.90. The higher Degree of Operating Leverage, the higher operating risk the company will take.

The industry rank for PhotoCure ASA's Degree of Operating Leverage or its related term are showing as below:

FRA:PHS's Degree of Operating Leverage is ranked worse than
86.39% of 933 companies
in the Drug Manufacturers industry
Industry Median: 1.09 vs FRA:PHS: 15.90

PhotoCure ASA  (FRA:PHS) Degree of Operating Leverage Explanation

Degree of Operating Leverage (DOL) is a leverage ratio that measures the sensitivity of a company’s operting income, also referred to as Earnings Before Interest and Taxes (EBIT), to fluctuations in its Revenue. DOL is a method used to quantify a company’s operating risk. This risk is related to the company's structure of variable costs and fixed costs. Since the fixed costs do not allow the company to adjust the operating costs, the operating risk rises with a higher fixed-to-variable costs proportion.

A high Degree of Operating Leverage indicates that the company’s fixed costs exceed its variable costs. By increasing the sales, the company can earn more profits. In addition, the company must be able to maintain relatively high sales to cover all fixed costs.

Be Aware

The use of operating leverage varies across different industries and business sectors, and the application of Degree of Operating Leverage (DOL) should be adjusted accordingly.


PhotoCure ASA Degree of Operating Leverage Related Terms


PhotoCure ASA Degree of Operating Leverage Historical Data

* Premium members only.

The historical data trend for PhotoCure ASA's Degree of Operating Leverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PhotoCure ASA Degree of Operating Leverage Chart

PhotoCure ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Degree of Operating Leverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.77 56.70 -7.88 -2.73 -45.81

PhotoCure ASA Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Degree of Operating Leverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -35.21 -28.39 -45.81 11.16 15.90

FRA:PHS vs ZTS, UTHR, VTRS: Degree of Operating Leverage Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, PhotoCure ASA's Degree of Operating Leverage, along with its competitors' market caps and Degree of Operating Leverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PhotoCure ASA Degree of Operating Leverage vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PhotoCure ASA's Degree of Operating Leverage distribution charts can be found below:

* The bar in red indicates where PhotoCure ASA's Degree of Operating Leverage falls into.


FRA:PHS
81GF Score
PhotoCure ASA FRA:PHS
Degree of Operating Leverage is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PhotoCure ASA Degree of Operating Leverage Calculation

PhotoCure ASA's Degree of Operating Leverage for the quarter that ended in Jun. 2026 is calculated as:

Degree of Operating Leverage=% Change in EBIT**/% Change in Revenue
=( 12.417 (Jun. 2026) / 2.07 (Jun. 2025) - 1 )/( 59.716 (Jun. 2026) / 44.81 (Jun. 2025) - 1 )
=4.9986/0.3326
=15.03***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of EBIT and Revenue was used to calculate Degree of Operating Leverage.
*** Please be aware that the Degree of Operating Leverage calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.

What does a Degree of Operating Leverage of 15.90 mean?
PhotoCure ASA (FRA:PHS) has a Degree of Operating Leverage of 15.90 as of Jun. 2026. Degree of Operating Leverage (DOL) measures the percentage change in EBIT for a unit change in Revenue. View historical data for PhotoCure ASA and its competitors. According to the industry distribution chart, PhotoCure ASA ranks #806 out of 933 companies in the Drug Manufacturers industry, placing it in the top 86.4%.
Is PhotoCure ASA's Degree of Operating Leverage too high?
PhotoCure ASA's current Degree of Operating Leverage is 15.90. The Drug Manufacturers industry median Degree of Operating Leverage is 1.09. PhotoCure ASA's value of 15.90 is 1358.7% above this industry median. Based on the distribution chart, PhotoCure ASA ranks #806 out of 933 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, PhotoCure ASA has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PhotoCure ASA's Degree of Operating Leverage compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, PhotoCure ASA ranks #806 out of 933 companies for Degree of Operating Leverage. This places PhotoCure ASA in the lower half of its industry. The industry median Degree of Operating Leverage is 1.09. PhotoCure ASA's value of 15.90 is 1358.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Degree of Operating Leverage for a Drug Manufacturers company?
The median Degree of Operating Leverage among Drug Manufacturers companies is 1.09, based on 933 companies in the industry. Companies in the top quartile (top 25%) have a Degree of Operating Leverage significantly above this median, while those in the bottom quartile fall well below. However, Degree of Operating Leverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PhotoCure ASA's current Degree of Operating Leverage of 15.90 is 1358.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Degree of Operating Leverage mean?
A high Degree of Operating Leverage can signal that a stock is expensive relative to its fundamentals. Degree of Operating Leverage (DOL) measures the percentage change in EBIT for a unit change in Revenue. View historical data for PhotoCure ASA and its competitors. For the Drug Manufacturers industry, the median Degree of Operating Leverage is 1.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PhotoCure ASA's current Degree of Operating Leverage is 15.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PhotoCure ASA stock overvalued right now?
Based on GuruFocus' analysis, PhotoCure ASA (FRA:PHS) is currently considered Modestly Undervalued. The stock's GF Value™ is €6.61, compared to a current price of €4.88 — trading 26.2% below its estimated fair value. The current Degree of Operating Leverage is 15.90 and 1358.7% above the Drug Manufacturers industry median of 1.09. PhotoCure ASA's overall GF Score™ is 81/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Degree of Operating Leverage calculated?
Degree of Operating Leverage is calculated from a company's financial statements. For PhotoCure ASA (FRA:PHS), the current Degree of Operating Leverage is 15.90 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PhotoCure ASA (FRA:PHS) Overvalued in 2026?

Based on GuruFocus' analysis, PhotoCure ASA stock appears to be undervalued. The current stock price of €4.88 is trading 26.2% below its estimated GF Value™ of €6.61. GuruFocus considers PhotoCure ASA to be Modestly Undervalued.

Key valuation signals for FRA:PHS:

  • Degree of Operating Leverage: 15.90
  • GF Value™: €6.61 vs. price of €4.88 (26.2% below fair value)
  • GF Score™: 81/100 with 1 warning sign
  • Industry Position: 1358.7% above the Drug Manufacturers median (#806 of 933)

No single metric tells the full story. See the FRA:PHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PhotoCure ASA Business Description

Address Hoffsveien 4, Oslo, NOR, 0275
PhotoCure ASA is a Norway-based business group associated with the research, development, production, distribution, marketing, and sales of pharmaceutical products and specialty pharmaceutical companies. The technology platform of the company is focused on the field of photodynamic diagnosis and treatment of cancer. The company has two operating segments of the group the Commercial franchise and the Development portfolio. It generates prime revenue from the Commercial franchise segment, which includes Hexvix and Cysview products. Its geographical segments are Nordic countries, Germany, France, Austria, the United Kingdom, BeNeLux, Italy, Other European countries, Canada, and the United States.
81GF Score

Get the complete analysis for FRA:PHS

Degree of Operating Leverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.88
Price
€6.61
GF Value